Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fusu mixture is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine. It is designed based on the 'Wen-Shen-Qian-Yang' (Warming Kidney and Subduing Yang) therapeutic principle to treat critical conditions such as sepsis-induced acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). The mixture aims to modulate the systemic inflammatory response and protect pulmonary function during severe infection. It is currently being evaluated in clinical trials to establish its efficacy and safety as an adjunctive treatment for patients with sepsis-related respiratory failure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fusu mixture.